STUDY SEARCH RESULTS

18 studies found for your search request:  vaccines

A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent human papillomavirus vaccine ...
Condition: Papillomavirus infections
Minimum Age: 9 years, Maximum Age: 15 years
Gender: Female
Study ID: NCT01254643
Status: Completed

A Study of V118E in Healthy Participants (V118E-003)
Condition: Healthy
Minimum Age: 18 years, Maximum Age: 49 years
Gender: All
Study ID: NCT07168915
Status: Recruiting
Has Enrolling Locations in US or Canada

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU...
Condition: Pneumococcal infections
Minimum Age: 42 days, Maximum Age: 90 days
Gender: All
Study ID: NCT03620162
Status: Completed

Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
Condition: Rotavirus gastroenteritis
Minimum Age: 6 weeks, Maximum Age: 12 weeks
Gender: Both
Study ID: NCT02062385
Status: Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumova...
Condition: Pneumococcal infections
Minimum Age: 50 years, Maximum Age: N/A
Gender: Both
Study ID: NCT02225587
Status: Completed




Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site